Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria

Abstract Ivermectin mass drug administration (MDA) in humans to reduce malaria vectors is yet another use for this remarkable medicine whose discoverers shared the 2015 Nobel Prize in Medicine with the discoverer of artemisinin. The malaria community should join those who have long used ivermectin M...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Author: Frank O. Richards
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2017
Subjects:
Malaria
Ivermectin
Albendazole
Lymphatic Filariasis
Mass Drug Administration
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Online Access:https://doi.org/10.1186/s12936-017-1830-z
https://doaj.org/article/c754db5a9da84fc893d7c536f8510015
Description
Summary:Abstract Ivermectin mass drug administration (MDA) in humans to reduce malaria vectors is yet another use for this remarkable medicine whose discoverers shared the 2015 Nobel Prize in Medicine with the discoverer of artemisinin. The malaria community should join those who have long used ivermectin MDA in an integrated battle to break transmission of three vector-borne parasitic diseases.

Similar Items